Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-064000
Filing Date
2021-11-10
Accepted
2021-11-10 20:19:36
Documents
2
Period of Report
2021-11-09

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2754
2 POA DOCUMENT poa.txt EX-24 3232
  Complete submission text file 0001209191-21-064000.txt   7446
Mailing Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 489-9000
RAPT Therapeutics, Inc. (Issuer) CIK: 0001673772 (see all company filings)

EIN.: 473313701 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DERMIRA, INC. 275 MIDDLEFIELD ROAD, SUITE 150 MENLO PARK CA 94025
Business Address
Lyons-Williams Lori (Reporting) CIK: 0001693564 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38997 | Film No.: 211398587